The following frequency criteria are used as the basis for evaluating undesirable effects: very common (>1/10); common (>1/100 to 1/10); uncommon (>1/1,000 to <1/100); rare (>1/10,000 to <1/1,000); very rare (<1/10,000); not known: (cannot be estimated from the available data).
Infections and infestations: Common: Vulvovaginitis.
Immune system disorders: Not known: Anaphylactic reactions including anaphylactic shock, hypersensitivity (see Precautions).
Nervous system disorders: Common: Headache, dizziness.
Gastrointestinal disorders: Common: Diarrhea, nausea, dyspepsia, abdominal pain.
Uncommon: Vomiting.
Not known: Antibiotic-associated colitis (see Precautions).
Skin and subcutaneous tissue disorders: Uncommon: Rash, urticaria, pruritus.
Not known: Angioedema.
View ADR Reporting Link